Dan Karlin - Mar 24, 2022 Form 4 Insider Report for Mind Medicine (MindMed) Inc. (MNMD)

Role
Chief Medical Officer
Signature
s/ Robert Barrow, Attorney-in-Fact
Stock symbol
MNMD
Transactions as of
Mar 24, 2022
Transactions value $
$0
Form type
4
Date filed
3/28/2022, 08:11 PM
Previous filing
Mar 1, 2022
Next filing
Mar 29, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction MNMD Subordinate Voting Shares Award $0 +950K +29.98% $0.00 4.12M Mar 24, 2022 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction MNMD Stock Option (Right to Buy) Award $0 +1.25M +85.09% $0.00 2.72M Mar 24, 2022 Subordinate Voting Shares 1.25M $1.18 Direct F2, F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 These shares represent restricted stock units ("RSUs"). Each RSU represents a contingent right to receive one subordinate voting share of the Issuer. The RSUs vest in 48 equal monthly installments beginning on April 24, 2022, subject, to the Reporting Person providing continuous service to the Issuer on each such vesting date.
F2 The option grant has an exercise price of $1.48 Canadian Dollars. This represents the exercise price in United States Dollars.
F3 The shares subject to the option vest and become exercisable with 1/48th of the total shares vesting monthly over 48 months from the vesting commencement date, March 24, 2022, subject to the Reporting Person providing continuous service to the Issuer as of each such vesting date.